Ismail Jatoi, MD, PhD, FACS, and Ann H. Partridge, MD, MPH, on the Movement Toward Bilateral Surgical Procedures

2014 San Antonio Breast Cancer Symposium

Ismail Jatoi, MD, PhD, FACS, of the University of Texas Health Science Center and Ann H. Partridge, MD, MPH, of the Dana-Farber Cancer Institute discuss the increasing movement away from breast conservation toward bilateral surgical procedures.

Prudence Francis, MD, and Hope Rugo, MD, on the Phase III SOFT Trial

Jame Abraham, MD, FACP, on Immunotherapy in Triple-Negative Breast Cancer

Ian E. Krop, MD, PhD, on Pictilisib in Metastatic Breast Cancer

Lisa A. Carey, MD, on the CALGB/Alliance 40603 Trial

Phase II Study of Trilaciclib in Pretreated Patients With Metastatic NSCLC Initiated PRESERVE 4

Safety of Stereotactic Body Radiotherapy for Treatment of Patients With Multiple Metastases

FDA ODAC Votes in Favor of Retaining Accelerated Approval for Bladder Cancer Treatments

Expert Panel–Endorsed Quality Measures for End-of-Life Care for Children With Cancer

One vs Two Doses of the BNT162b2 COVID-19 Vaccine in Patients With Cancer: Immunogenicity and Efficacy

Ismail Jatoi, MD, PhD, FACS, and Ann H. Partridge, MD, MPH, on the Movement Toward Bilateral Surgical Procedures

Related Videos

Jack Cuzick, PhD, on the IBIS-I Trial